Alexey Vyacheslavovich Stepanov;Dmitry Dmitrievich Genkin;Alexander Gabibovich Gabibov;OPKO Pharmaceuticals, LLC;The Scripps Research Institute;Bioorganic Chemistry, Russian Academy of Sciences;PJSC P
Described are methods for providing personalized medicine for the treatment of B cell malignancies including lymphoma. The methods make use of Chimeric Antigen Receptor (CAR) technology.